SG Americas Securities’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-90,000
Closed -$14K 3824
2021
Q2
$14K Buy
+90,000
New +$2.73M ﹤0.01% 2790
2019
Q2
Sell
-18,400
Closed -$4K 3087
2019
Q1
$4K Sell
18,400
-173,100
-90% -$4.13M ﹤0.01% 3320
2018
Q4
$10K Buy
191,500
+91,500
+92% +$2.18M ﹤0.01% 2941
2018
Q3
$218K Buy
100,000
+56,200
+128% +$1.29M ﹤0.01% 2518
2018
Q2
$11K Sell
43,800
-1,411,200
-97% -$29.2M ﹤0.01% 3261
2018
Q1
$35K Buy
+1,455,000
New +$27.1M ﹤0.01% 3121

Other funds holding BHC

SG Americas Securities's BHC Position: Q2 2026 in Review

SG Americas Securities increased its Bausch Health (BHC) stake by 37,279% in Q2 2026, buying an estimated $29.6M and bringing the position to 5,535,771 shares worth $27.3M. The position accounts for 0.02% of the portfolio, ranked #508.

SG Americas Securities first reported a position in BHC in Q2 2013 and has held it in 40 quarters since. The position peaked at $41M in Q2 2025. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • SG Americas Securities held 5,535,771 shares of Bausch Health worth $27.3M as of Q2 2026.
  • SG Americas Securities bought 5,520,961 Bausch Health shares in Q2 2026, an estimated $29.6M.
  • Bausch Health made up 0.02% of SG Americas Securities's portfolio in Q2 2026, its #508 holding.
  • SG Americas Securities first reported a position in Bausch Health in Q2 2013 and has held it in 40 quarters since.
  • SG Americas Securities's Bausch Health position peaked at $41M in Q2 2025.
  • 222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.